Stanford Researchers Use Single-Cell Mass Cytometry to Predict Recovery Time from Surgery
September 26, 2014
SOUTH SAN FRANCISCO, Calif.-- Researchers at Stanford University have demonstrated the ability to predict the recovery time of patients who underwent surgical trauma. Convalescence after surgery varies significantly from patient to patient—often with protracted recovery periods resulting in personal suffering as well as substantial societal and economic costs. Now, using the deep profiling capabilities of [...]
September 25, 2014
STEMCELL Technologies has received $949,500 in repayable assistance from the Western Innovation (WINN) Initiative for an exciting project to develop tools and assays for three-dimensional (3D) cell culture. Led by Dr. Steven Woodside, Director of Particle Chemistry and Engineering, and Dr. Eric Jervis, Principal Scientist, the project builds on STEMCELL Technologies’ extensive experience in developing [...]
GENAPSYS ANNOUNCES KEY HIRE TO SENIOR MANAGEMENT TEAM
September 25, 2014
Redwood City, California –– GenapSys Inc., the developer of the GENIUS DNA Sequencing System, today announced the appointment of Mark Pratt, Ph.D. as Vice President of Product Development. In his new role, Dr. Pratt will be a member of the GenapSys leadership team reporting to Hesaam Esfandyarpour, PhD, Founder & CEO. Most recently, Dr. Pratt [...]
BellBrook Labs and UW-Madison Team Awarded NCI Contract to Develop Next Generation Cancer Models
September 25, 2014
Madison, WI -- The National Cancer Institutes has awarded a $1.75M Small Business Innovative Research (SBIR) contract to BellBrook Labs for a collaborative effort with researchers at the University of Wisconsin-Madison to develop more realistic models for breast and ovarian cancer. The research will use imaging and microfabrication technology developed by the UW team to [...]
September 25, 2014
CARLSBAD, Calif. -- Thermo Fisher Scientific and pharmaceutical companies GlaxoSmithKline and Pfizer have entered into an agreement to develop a universal next-generation sequencing (NGS) oncology test for solid tumors that will serve as a companion diagnostic for multiple drug programs. Thermo Fisher intends to submit this test for premarket approval to the Food and Drug [...]
Horizon Discovery Group plc Signs Master Services Agreement for Approximately $1.2 million
September 25, 2014
Cambridge, UK -- Horizon Discovery Group plc (LSE: HZD) (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announces that its business unit Horizon Diagnostics has signed a Master Services Agreement with a major global diagnostic development company and a US biopharmaceutical company to support the [...]
Nanoscience Instruments Announces New PoroMetric Software for Phenom Desktop SEM
September 25, 2014
Phoenix, AZ -- The visualization and analysis of pores is easier than ever before with the Phenom desktop and integrated PoroMetric from Nanoscience Instruments. The combination of speed, ease of use and superb imaging quality of the Phenom and pore analysis software of PoroMetric creates a powerful tool for inspecting a wide range of samples [...]
Silicon Biosystems Appoints Farideh Bischoff, Ph.D. as Executive Director of Scientific Affairs
September 24, 2014
San Diego, CA -- Silicon Biosystems, Inc. announced the appointment of Farideh Bischoff, Ph.D. as Executive Director of Scientific Affairs. Dr. Bischoff has more than 20 years of experience in reproductive genetics and cancer research and diagnostics. Prior to joining Silicon Biosystems, Dr. Bischoff served as Vice President of Translational Research and Clinical Development at [...]
Bibby Scientific Ltd acquires PCRmax Ltd
September 24, 2014
Bibby Scientific, one of the largest manufacturers of quality bench top science equipment, has purchased 100% of the share capital of PCRmax, a UK based sales and distribution Company set up specifically to capture a significant market share of the standard (PCR) and quantitative PCR (QPCR) markets. They are also the registered owners of the [...]
Agilent Technologies Thought Leader Award Supports Cancer Stem Cell Research at Mount Sinai
September 24, 2014
SANTA CLARA, Calif. -— Agilent Technologies, Inc. (NYSE: A) today announced that Carlos Cordon-Cardo, M.D., Ph.D., of the Mount Sinai Health System, has received an Agilent Thought Leader Award in recognition of his groundbreaking work in molecular and translational pathology. Dr. Cordon-Cardo is the Irene Heinz Given and John LaPorte Given Professor and chair of [...]

